| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/08/2011 | CN101084981B Medicinal preparation for cancer auxiliary treatment and its preparation method |
| 06/08/2011 | CN101080404B Pyrimidinylisoxazol derivative |
| 06/08/2011 | CN101077873B Novel NEO-clerodane type diterpene compound and application thereof |
| 06/08/2011 | CN101062043B Application of 3, 4, 5, 4'-tetramethyl diphenylethane-3'-O-disodium phosphate in the anti-cancer medicine and the transferring medicine thereof |
| 06/08/2011 | CN101032481B Application of traditional Chinese medicine justicia lignanoids part as antineoplastic medicine |
| 06/07/2011 | US7956093 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 06/07/2011 | US7956084 Phenyl thiophene carboxamide compounds as inhibitors of the enzyme IKK-2 |
| 06/07/2011 | US7956060 Pyrimidine derivative compound |
| 06/07/2011 | US7956058 Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 06/07/2011 | US7956053 Inhibitors of tyrosine kinases |
| 06/07/2011 | US7956036 Polypeptide and DNA thereof useful as a neovascular marker |
| 06/07/2011 | US7955626 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester |
| 06/07/2011 | US7955614 Microfabricated nanopore device for sustained release of therapeutic agent |
| 06/07/2011 | US7955600 Attenuated salmonella SP12 mutants as antigen carriers |
| 06/07/2011 | CA2628607C Androgen synthesis inhibitors |
| 06/07/2011 | CA2581025C Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one |
| 06/07/2011 | CA2567306C Radiosensitizer |
| 06/07/2011 | CA2484816C Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds |
| 06/07/2011 | CA2456977C Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/07/2011 | CA2442971C Chemotherapeutic induction of egr-1 promoter activity |
| 06/07/2011 | CA2441845C Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 06/07/2011 | CA2441436C Methods and kits for determing a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a dna repair enzyme and a cancer |
| 06/07/2011 | CA2435685C Desaturase genes and uses thereof |
| 06/07/2011 | CA2423868C Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 06/07/2011 | CA2418422C Novel kallikrein gene |
| 06/07/2011 | CA2405705C The treatment of respiratory diseases |
| 06/07/2011 | CA2404431C Guanylyl cyclase c in the detection of stomach and esophageal cancers |
| 06/07/2011 | CA2361837C Human papilloma virus vaccine formulations |
| 06/03/2011 | WO2011066542A2 6-substituted estradiol derivatives and methods of use |
| 06/03/2011 | WO2011066537A1 Nitroxide therapy for the treatment of von hippel - lindau disease (vhl) and renal clear cell carcinoma (rcc) |
| 06/03/2011 | WO2011066521A2 Compounds with reduced ring size for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same |
| 06/03/2011 | WO2011066506A1 2-METHYLENE-19,26-NOR-(20S)-1α-HYDROXYVITAMIN D3 |
| 06/03/2011 | WO2011066453A2 Pacap and related proteins in the treatment of cancer |
| 06/03/2011 | WO2011066417A2 Antibodies and conjugates for modulators of angiogenesis |
| 06/03/2011 | WO2011066390A2 Nanoscale adjuvants and related pharmaceutical compositions and methods |
| 06/03/2011 | WO2011066379A2 METHOD OF REDUCING INTRATUMORAL pHe AND ACID-MEDIATED INVASION |
| 06/03/2011 | WO2011066378A2 Antagonists of il-6 to prevent or treat thrombosis |
| 06/03/2011 | WO2011066374A2 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever |
| 06/03/2011 | WO2011066371A2 Antibodies to il-6 and use thereof |
| 06/03/2011 | WO2011066369A2 Antagonists of il-6 to raise albumin and/or lower crp |
| 06/03/2011 | WO2011066352A1 An amorphous and a crystalline form of genz 112638 hemitartrat as inhibitor of glucosylceramide synthase |
| 06/03/2011 | WO2011066316A2 Treating neoplasms with neurotoxin |
| 06/03/2011 | WO2011066260A2 Formulations comprising aminosterols |
| 06/03/2011 | WO2011065923A1 Treatment and prevention of cancers associated with intracellular oncoproteins by antibody therapy or vaccination |
| 06/03/2011 | WO2011065677A2 Pharmaceutical composition for treating cancer |
| 06/03/2011 | WO2011065545A1 5-FLUOROURACIL COMPOUND HAVING dUTPase-INHIBITING ACTIVITY OR SALT THEREOF |
| 06/03/2011 | WO2011065541A1 Anti-tumor effect potentiator |
| 06/03/2011 | WO2011065420A1 Method for manufacturing a 6-substituted-1-methyl-1h-benzimidazole derivative, and manufacturing intermediate from said method |
| 06/03/2011 | WO2011064663A1 Combination treatment employing belinostat and bicalutamide |
| 06/03/2011 | WO2011064657A2 Quinazolin-4(3a)-one derivatives and methods of use thereof |
| 06/03/2011 | WO2011064559A2 Novel inositol phosphate derivatives |
| 06/03/2011 | WO2011064328A1 Triazolopyridine derivatives |
| 06/03/2011 | WO2011064256A1 A new crystalline form of pemetrexed disodium |
| 06/03/2011 | WO2011064250A1 Novel naphthyridine derivatives and the use thereof as kinase inhibitors |
| 06/03/2011 | WO2011064211A1 Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroaryls |
| 06/03/2011 | WO2011064141A1 Sultam derivatives |
| 06/03/2011 | WO2011063908A1 Triazolopyridines |
| 06/03/2011 | WO2011063907A1 Substituted triazolopyridines |
| 06/03/2011 | WO2011063753A1 Traditional chinese medicine composition for treating oral ulcer and tumor, preparation method and use thereof |
| 06/03/2011 | WO2011063615A1 Macrocyclic amides, pharmaceutical compositions, preparation methods and uses thereof |
| 06/03/2011 | WO2011063602A1 Use of 5-substituted-2, 4-thiazolidinediones in preparation of medicaments for modulating insulin-like growth factor 1 receptor |
| 06/03/2011 | WO2011063523A1 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume |
| 06/03/2011 | WO2011063507A1 Brain tumor targeting peptides and methods |
| 06/03/2011 | WO2011063456A1 Methods and compositions for increasing sensitivity to tyrosine kinase inhibitors |
| 06/03/2011 | WO2011063455A1 Modulation of epidermal growth factor receptor ligands |
| 06/03/2011 | WO2011041920A3 Nutraceutical composition that comprises extract of shilajit, folic acid, vitamin b12 and vitamin b6 and the use thereof for preventing and/or treating neurodegenerative diseases and/or the cognitive deterioration associated with cerebral ageing |
| 06/03/2011 | WO2011041579A3 (20S,22E)-2-METHYLENE-19-NOR-22-ENE-1α,25-DIHYDROXYVITAMIN D3 ANALOGS |
| 06/03/2011 | WO2011033225A3 Substituted 3-amino-cinnolin-4(1h)-one derivatives, preparation thereof, and therapeutic use thereof |
| 06/03/2011 | WO2011030332A3 Methods for hematopoietic precursor mobilization |
| 06/03/2011 | WO2011024168A3 Sustained release delivery systems for the prevention and treatment of head and neck cancers |
| 06/03/2011 | WO2011019630A3 Treatment of brain metastases with inhibitors of endothelin receptors in combination with a cytotoxic chemotherapy agent |
| 06/03/2011 | WO2011011453A3 Phenotyping tumor-infiltrating leukocytes |
| 06/03/2011 | WO2011011384A3 Synthesis of dendrimer conjugates |
| 06/03/2011 | WO2011009854A3 Vaccine for the prevention of acute lymphoblastic leukemia |
| 06/03/2011 | WO2010140834A3 Nucleic acid aptamer specifically binding to pancreatic cancer cells or tissues and use thereof |
| 06/03/2011 | WO2010135429A8 Compositions for modulating a kinase cascade and methods of use thereof |
| 06/03/2011 | CA2782280A1 Anti-tumor effect potentiator |
| 06/03/2011 | CA2782146A1 Small pyrimidine derivatives and methods of use thereof |
| 06/03/2011 | CA2782127A1 Quinazolin-4(3a)-one derivatives and methods of use thereof |
| 06/03/2011 | CA2782012A1 Triazolopyridine derivatives |
| 06/03/2011 | CA2781915A1 Triazolopyridines |
| 06/03/2011 | CA2781914A1 Substituted triazolopyridines |
| 06/03/2011 | CA2781889A1 2-methylene-19,26-nor-(20s)-1.alpha.-hydroxyvitamin d3 |
| 06/03/2011 | CA2781887A1 Compositions and methods for the diagnosis and treatment of tumor |
| 06/03/2011 | CA2781818A1 Novel naphthyridine derivatives and the use thereof as kinase inhibitors |
| 06/03/2011 | CA2781800A1 Method for manufacturing a 6-substituted 1-methyl-1h-benzimidazole derivative and an intermediate of said method |
| 06/03/2011 | CA2781676A1 An amorphous and a crystalline form of genz 112638 hemitartrate as inhibitor of glucosylceramide synthase |
| 06/03/2011 | CA2781627A1 6-substituted estradiol derivatives and methods of use |
| 06/03/2011 | CA2781572A1 Methods and compositions for increasing sensitivity to tyrosine kinase inhibitors |
| 06/03/2011 | CA2781571A1 Modulation of epidermal growth factor receptor ligands |
| 06/03/2011 | CA2781318A1 Brain tumor targeting peptides and methods |
| 06/03/2011 | CA2780998A1 Immunomodulatory compounds for the restoration of vitamin d sensitivity in vitamin d resistant tumor cells |
| 06/03/2011 | CA2779089A1 Sultam derivatives |
| 06/03/2011 | CA2778714A1 Targeted binding agents against b7-h1 |
| 06/03/2011 | CA2776513A1 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume |
| 06/02/2011 | US20110130707 Thiadiazole Compounds and Uses Thereof |
| 06/02/2011 | US20110130469 Compositions and methods relating to resveratrol |
| 06/02/2011 | US20110130468 Hydroxylated tolans and related compounds in the treatment of a cancer |
| 06/02/2011 | US20110130453 Aminoalkylphenyl antagonists of prostaglandin d2 receptors |
| 06/02/2011 | US20110130449 Assay for Monitoring Activity of Jmjd6 |